Endocrinologists share ‘practical’ COVID-19 advice
The consensus recommendations recognise the increased risk of the pandemic for patients with diabetes
Severe COVID-19 can lead to a ‘tremendous’ requirement for insulin in people with type 2 diabetes while those with type 1 disease are at risk of severe ketoacidosis, according to an international panel of endocrinologists.
Some 20 eminent specialists, including Professor Paul Zimmet from Monash University in Melbourne, offer tips for treating patients with diabetes and COVID-19 in a commentary in the Lancet Diabetes and Endocrinology.
